Transition from Cytomegalovirus Antigenemia Assay and Whole-Blood Quantitative PCR to Automated Plasma Quantitative PCR in Solid Organ Transplant Recipients: Correlation of Viral Loads and Impact on Treatment Eligibility Based on a Single-Center Retrospective Study

Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0

초록

<p style="margin-left:0px; margin-right:0px">Background: Cytomegalovirus (CMV) antigenemia assay (AG) and whole-blood (WB) quantitative (q)PCR have long been used for monitoring CMV reactivation in solid organ transplant (SOT) recipients. Automated plasma qPCR has enabled faster turnaround and timely intervention. We compared automated plasma qPCR with conventional methods to determine CMV pre-emptive therapy thresholds. <p style="margin-left:0px; margin-right:0px">Methods: In this single-center retrospective study, liver transplant (LT) and kidney transplant (KT) recipients underwent AG, WB qPCR, and plasma qPCR on the same day. Correlations between these assays were assessed using Spearman's rank correlation, linear, and Tobit regression. qPCR performance was evaluated using ROC analysis, with AG thresholds as the reference standard. <p style="margin-left:0px; margin-right:0px">Results: In total, 618 samples from 248 patients were analyzed. WB and plasma qPCR viral loads showed strong correlation (Spearman rho=0.854,P<0.001), with higher viral loads in WB. Among 317 samples with quantifiable CMV DNA in both assays, WB (beta=0.81; R-2=0.371) and plasma (beta=0.77; R-2=0.387) qPCR showed moderate correlations with AG (P<0.001). A linear regression equation was derived: log(10)(plasma DNA [IU/mL])=0.77 & times;log(10)(AG cells/200,000 white blood cells)+2.81. Based on AG thresholds ( >= 5 for LT; >= 25 for KT), clinical feasibility, and treatment burden, institutional plasma qPCR thresholds of 2,000 IU/mL (LT) and 10,000 IU/mL (KT) were established. <p style="margin-left:0px; margin-right:0px">Conclusions: By establishing organ-specific plasma qPCR thresholds, this study provides a framework for transitioning from AG-or WB-based monitoring to automated plasma qPCR-guided CMV surveillance.

키워드

Antigenemia assay; Cytomegalovirus Infections; Organ Transplantation; PCR; REAL-TIME PCR; PREEMPTIVE GANCICLOVIR THERAPY; INTERNATIONAL STANDARD; ORAL VALGANCICLOVIR; PP65 ANTIGENEMIA; CMV INFECTION; DISEASE; DNA; PREVENTION; EFFICACY
제목
Transition from Cytomegalovirus Antigenemia Assay and Whole-Blood Quantitative PCR to Automated Plasma Quantitative PCR in Solid Organ Transplant Recipients: Correlation of Viral Loads and Impact on Treatment Eligibility Based on a Single-Center Retrospective Study
저자
Lee, Seung Hoo; Kim, Tae Yeul; Yang, Jinyoung; Huh, Kyungmin; Cho, Sun Young; Kang, Cheol-In; Chung, Doo Ryeon; Peck, Kyong Ran; Park, Sunghae; Lee, Kyo Won; Park, Jae Berm; Oh, Namkee; Rhu, Jinsoo; Choi, Gyu-Seong; Kim, Jongman; Huh, Wooseong; Huh, Hee Jae; Kang, Eun-Suk; Ko, Jae-Hoon
DOI
10.3343/alm.2025.0376
발행일
2026-09
유형
Article
저널명
Annals of Laboratory Medicine
권
46
호
5
페이지
577 ~ 585